Angiography Guided CABG Still Adequate

Fractional Flow reserve (FFR) guided myocardial revascularization surgery (CABG) has similar graft failure rate and clinical outcomes as angiography guided CABG.

El uso del ultrasonido intravascular en la angioplastia de tronco no protegido se asocia con mejores resultados en comparación con la angioplastia guiada solo por angiografía.When planning PCI, the value of FFR for lesion assessment pose no questions, but we know little when it comes to CABG. Since the early start, back when Dr. Mason Sones performed catheterizations and Dr. Rene Favaloro performed CABG procedures, surgeons have planned strategy based on angiographic assessment.  

 

This randomized study assessed graft patency and clinical outcomes after FFR guided CABG vs. angiography guided CABG.


Read also: Outcomes of MAIN-COMPARE: A 10-Year Follow-Up for a Historical Rivalry.


A total 100 patients referred to surgery were randomized to angiography vs FFR guided CABG.

 

In the FFR group, coronary lesions with FFR > 0.8 were deferred and a new strategy was planned to connect the grafts, while in the angiography guided group surgeons were blind to FFR values.

 

Primary end point was graft failure percentage in relation to the total number of grafts at 6 months.


Read also: Lotus Returns with New Strength and the FDA Approval to Compete with Sapien3 and CoreValve Evolut R.


Angiographic follow up was reached in 72 patients (39 vs 33 in the FFR group and angiography respectively).

 

Graft failure rate was similar in both groups (16% vs 12%; p=0.97). Graft rates for deaths, infarction and stroke resulted similar and there were no differences at long term.

 

After 6 months, differed lesions (n=24) showed a significant reduction of mean value compared to baselines (0.89 ± 0.05 vs. 0.81 ± 0.11; p=0.002). Baseline FFR did not affect graft patency.

 

Conclusion

As in the beginning, angiographies continue to be the adequate method when it comes to planning CABG. FFR did not predict graft patency and invasive follow-up at 6 moths showed a significant drop of this value compared to the baseline values of deferred lesions.

 

Original title: Fractional Flow Reserve Versus Angiographically-Guided Coronary Artery Bypass Grafting.

Reference: Anne Langhoff Thuesen et al. J Am Coll Cardiol 2018;72:2732–43.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...